For more information or to register for this event, visit Beyond 3+3: Rethinking Early-Phase Oncology Study Design.
GOLETA, Calif.--(BUSINESS WIRE)--Serimmune, a leader in understanding the antibody repertoire's role in human disease, announced today the publication of a study in Nature in which their proprietary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback